Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia

NCT06490627 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

54

Enrollment

OTHER_GOV

Sponsor class

Conditions

Fetal Hemoglobin
Thalassemia Major
Genetic Disease

Interventions

DRUG: Thalidomide
DRUG: Thalidomide

Sponsor

National Institute of Blood and Marrow Transplant (NIBMT), Pakistan